发明名称 |
TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD |
摘要 |
The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The subject invention also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient.
|
申请公布号 |
US2013272996(A1) |
申请公布日期 |
2013.10.17 |
申请号 |
US201213712398 |
申请日期 |
2012.12.12 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES, LTD.;TEVA PHARMACEUTICAL INDUSTRIES, LTD. |
发明人 |
TARCIC NORA;BAR-ZOHAR DAN;KOFLER DINA |
分类号 |
A61K31/4704;A61K45/06 |
主分类号 |
A61K31/4704 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|